Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum | Business Wire
Reviewing The Takeda-Shire Merger (NASDAQ:SHPG) | Seeking Alpha
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WO
Massive Takeda Pharma buyout of Shire a high-risk move with uncertain rewards - The Mainichi
Shire agrees $32bn takeover of Baxalta | Financial Times
Takeda to sell nearly new Shire plant with 200 employees | Fierce Pharma
News Release
Takeda Acquisition Of Shire Officially Closes, CEO Christophe Weber Shares His Plans For The Future
Japan drug giant Takeda tumbles as Shire recommends $64 bn offer
Takeda finally snags Shire in $62 billion deal
Shire and Takeda come to terms with a $64B deal, the biggest pharma M&A in years | Fierce Pharma
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WO
Shire rejects £42.4bn Takeda offer as Allergan rules itself out | Financial Times
After profits dip Takeda may find solace in Shire merger, says GlobalData - European Pharmaceutical Manufacturer
Takeda Pharmaceutical Company Ltd's proposed takeover of Shire PLC receives conditional EU clearance
Takeda Pharmaceutical Agrees $62.4 Billion Takeover of Shire - TheStreet
Shire and Takeda to announce preliminary deal after breakthrough in merger talks: Reuters, citing sources
After profits dip Takeda may find solace in Shire merger, says GlobalData - European Pharmaceutical Manufacturer
Takeda takes biggest gamble of 2018 with Shire merger -
Pharma giant Takeda enters into $7.5bn loan agreement to fund Shire takeover
Takeda's Shire takeover to bring $963 million fee bonanza | Reuters
SHP647 may take a back seat to Entyvio after Takeda-Shire merger
Takeda and Shire Agree Merger Terms | CHEManager
Takeda completes Shire acquisition - PharmaTimes
Takeda breaks into top 20 largest pharmas with Shire merger | Pharmaphorum
